Cargando…
Pharmacogenomics of anticoagulants: steps toward personal dosage
Warfarin and other coumarin anticoagulants are widely used clinically, but currently dosing is determined individually on the basis of patient response. There is increasing evidence that genetic factors, together with several non-genetic patient-specific factors, are important determinants of stable...
Autor principal: | Daly, Ann K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651584/ https://www.ncbi.nlm.nih.gov/pubmed/19348697 http://dx.doi.org/10.1186/gm10 |
Ejemplares similares
-
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
por: Greene, Robert, et al.
Publicado: (2009) -
Pharmacogenomics of sickle cell disease: steps toward personalized medicine
por: Husain, Marium, et al.
Publicado: (2017) -
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015) -
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
por: Avery, Peter, et al.
Publicado: (2009) -
Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013)